Literature DB >> 34676026

KRAS Mutant Combination Therapy for the Effective Treatment of Cancer.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 34676026      PMCID： PMC8521612          DOI： 10.1021/acsmedchemlett.1c00466

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  5 in total

Review 1.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

Review 2.  Drugging "undruggable" genes for cancer treatment: Are we making progress?

Authors:  Michael J Duffy; John Crown
Journal:  Int J Cancer       Date:  2020-08-07       Impact factor: 7.396

Review 3.  RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.

Authors:  Umberto Malapelle; Francesco Passiglia; Chiara Cremolini; Maria Lucia Reale; Francesco Pepe; Pasquale Pisapia; Antonio Avallone; Diego Cortinovis; Alfonso De Stefano; Matteo Fassan; Gabriella Fontanini; Domenico Galetta; Calogero Lauricella; Angela Listì; Fotios Loupakis; Fabio Pagni; Filippo Pietrantonio; Sara Pilotto; Luisella Righi; Andrea Sartore Bianchi; Hector Soto Parra; Marcello Tiseo; Michela Verzè; Giancarlo Troncone; Silvia Novello
Journal:  Eur J Cancer       Date:  2021-02-12       Impact factor: 9.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.